Analysts Set The Clorox Company (NYSE:CLX) PT at $156.54

The Clorox Company (NYSE:CLX) has been assigned a consensus rating of “Reduce” from the fifteen research firms that are presently covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and one has given a buy recommendation to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $156.07.

A number of research analysts have issued reports on the stock. Wells Fargo & Company upgraded shares of Clorox from an “underweight” rating to an “equal weight” rating and increased their target price for the stock from $155.00 to $157.00 in a research report on Tuesday, January 7th. DA Davidson increased their target price on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and increased their target price for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Royal Bank of Canada restated a “sector perform” rating and set a $150.00 target price on shares of Clorox in a research report on Thursday. Finally, JPMorgan Chase & Co. increased their target price on shares of Clorox from $167.00 to $171.00 and gave the stock a “neutral” rating in a research report on Thursday, January 16th.

Institutional Investors Weigh In On Clorox

A number of large investors have recently bought and sold shares of the stock. Brooklyn Investment Group lifted its position in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares in the last quarter. Prospera Private Wealth LLC bought a new position in shares of Clorox during the third quarter valued at about $27,000. Continuum Advisory LLC lifted its position in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after purchasing an additional 138 shares in the last quarter. Quarry LP lifted its position in shares of Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares in the last quarter. Finally, Asset Planning Inc bought a new position in shares of Clorox during the fourth quarter valued at about $32,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Performance

Shares of NYSE:CLX opened at $158.60 on Monday. The company’s 50 day moving average price is $162.76 and its two-hundred day moving average price is $158.35. Clorox has a 12-month low of $127.60 and a 12-month high of $171.37. The firm has a market cap of $19.63 billion, a PE ratio of 55.26, a PEG ratio of 2.91 and a beta of 0.42. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.08%. The ex-dividend date is Wednesday, January 29th. Clorox’s payout ratio is 170.03%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.